𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic factors in prostate cancer patients treated with arc radiotherapy

✍ Scribed by Lopez Guerra, J.; Matute, R.; Acevedo, C.; Isa, N.; Lengua, R.; Praena-fernandez, J.; Ortiz, M.; Jaen, J.; Azinovic, I.


Book ID
122186203
Publisher
Wielkopolskie Centrum Onkologii
Year
2013
Tongue
Polish
Weight
55 KB
Volume
18
Category
Article
ISSN
1507-1367

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Prostate specific antigen density as a p
✍ Alan Pollack; Scott Lankford; Gunar K. Zagars; R. Joseph Babaian πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 632 KB

## BACKGROUND. The pretreatment serum prostate specific antigen level (PSAL) is the most significant predictor of biochemical and local failure in patients treated with definitive radiotherapy. The role of prostate specific antigen (PSA) density (PSAD) relative to PSAL for such patients is controv